News
DDi selected by UK-Based $2B Medical Device company for streamlining Regulatory strategy, intelligence and Assessments
06 Nov 2025: A leading $2 Billion UK-headquartered medical device manufacturer valued has selected DDi’s AI powered Reg Intel platform to enhance its global regulatory intelligence and compliance operations. The adoption reflects increasing industry focus on automated, real-time regulatory process management as companies navigate evolving global requirements across the U.S., EU, UK, and emerging markets
DDi’s Reg Intel platform provides continuous regulatory updates, structured intelligence, and proactive change alerts, enabling regulatory and quality teams to respond quickly and reduce manual monitoring efforts. Its built-in AI capabilities help harmonize regulatory information, streamline assessment workflows, and support faster submission readiness.
After a detailed evaluation, the company chose DDi’s Reg Intel platform for its depth of coverage, data accuracy, AI based workflows, and seamless integration with internal systems. The implementation is expected to improve compliance preparedness, accelerate market access efforts, and strengthen audit readiness.
A DDi spokesperson stated, “Global manufacturers are prioritizing digital transformation to stay ahead of regulatory changes. DDi’s Reg Intel platform enables smarter, proactive decision-making and change assessment implementations”
Let's talk about how DDi can help you